Paragon Associates & Paragon Associates Ii Joint Venture Akoya Biosciences, Inc. Transaction History
Paragon Associates & Paragon Associates Ii Joint Venture
- $39.7 Million
- Q1 2025
A detailed history of Paragon Associates & Paragon Associates Ii Joint Venture transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Paragon Associates & Paragon Associates Ii Joint Venture holds 671,000 shares of AKYA stock, worth $865,590. This represents 2.35% of its overall portfolio holdings.
Number of Shares
671,000
Previous 801,000
16.23%
Holding current value
$865,590
Previous $1.83 Million
49.18%
% of portfolio
2.35%
Previous 4.32%
Shares
4 transactions
Others Institutions Holding AKYA
# of Institutions
62Shares Held
12.6MCall Options Held
40.4KPut Options Held
1K-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$6.06 Million6.47% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$1.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$1.54 Million0.0% of portfolio
-
Trium Capital LLP London, X0605KShares$781,0890.09% of portfolio
-
State Street Corp Boston, MA494KShares$636,9890.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $48.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...